Novartis Cosentyx® receives FDA approval for the treatment of children and adolescents with enthesitis-related arthritis and psoriatic arthritis
EAST HANOVER, N.J., Dec. 22, 2021 /PRNewswire/ -- Novartis, a pacesetter in rheumatology and immuno-dermatology, in the present day introduced ...